When Mayo Clinic scientists Jonathan and Paula Hoyne learned that their 7-year-old son had type 1 diabetes, they began learning anything they could about the disease, including how they could help others.
It was all things Mayo Clinic at a past Minnesota Twins game when Dr. John Noseworthy threw out the first pitch, Mayo surgeons shared their musical talents, and fans went home with Mayo-approved swag.
Joseph Maleszewski, M.D., Co-Medical Director of Tissue Registry and Consultant in the Division of Anatomic Pathology in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, comments on the expansion of Mayo Clinic’s Tissue Registry Building.
Joseph Maleszewski, M.D., Consultant in the Division of Anatomic Pathology in the Department of Laboratory Medicine and Pathology (DLMP) at Mayo Clinic in Rochester, Minnesota, and Melanie Bois, M.D., Senior Associate Consultant in the Division of Anatomic Pathology in DLMP at Mayo Clinic, are featured on the Top 100 “Power List” from The Pathologist.
Each month, this series will focus on Mayo Clinic’s values and feature quotes and stories from our founders that exemplify those values. This month’s featured values are Innovation and Excellence.
For 50 years, the Bernard H. van der Steen Trust has helped ease the financial burden of cancer patients in need at Mayo Clinic.
On the September 22 broadcast of Mayo Clinic Radio, Yi Lin, M.D., Ph.D., a hematologist at Mayo Clinic and Chair of the Cellular Therapeutics Cross-Disciplinary Group in the Mayo Clinic Cancer Center, explained how chimeric antigen receptor T-cell therapy (CAR T-cell therapy) works and where the research is headed.
In a recent Q&A in CAP Today, Mohamed Salama, M.D., Medical Director of Mayo Medical Laboratories, discusses the use of CD30 as a predictive marker for therapy.
Yi Lin, M.D., Ph.D., a hematologist at Mayo Clinic and Chair of the Cellular Therapeutics Cross-Disciplinary Group in the Mayo Clinic Cancer Center, spoke at the Individualizing Medicine Conference, “Advancing Care through Genomics,” on CAR T-cell therapy. In this new cancer treatment, T cells are genetically modified to equip them to recognize and destroy cancer cells.
Dr. Charles W. Mayo’s story isn’t as well-known as some of his family members’ stories, but his life of serving others and showing compassion to his patients made a lasting impression on those who knew him.
Aziza Nassar, M.D., was selected as the new Chair of the Florida Division of Laboratory Medicine. She will enter the role on September 19.
S. Vincent Rajkumar, M.D., has received the 2018 Distinguished Mayo Clinic Investigator Award. The Distinguished Mayo Clinic Investigator Award is presented to individuals whose research careers demonstrate evidence of great distinction, high distinguished scholarship, creative achievement, and excellence in education and administrative responsibilities.
Newly discovered BRCA1 mutations known as “variants of unknown significance” (or VUS) could be harmful, making a woman’s risk of developing breast cancer as high as 72%. Fergus Couch, Ph.D., Chair of the Division of Experimental Pathology and Laboratory Medicine at Mayo Clinic, discusses the issue.